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Abstract
Cells use both deterministic and stochastic mechanisms to generate cell–to-cell heterogeneity,
which enables the population to better withstand environmental stress. Here we show that, within
a clonal population of mycobacteria, there is significant deterministic heterogeneity in elongation
rate that arises because mycobacteria grow in an unusual, unipolar fashion. Division of the
asymmetrically growing mother cell gives rise to daughter cells that differ in elongation rate and
size. Because the mycobacterial cell division cycle is governed by time not cell size, rapidly
elongating cells do not divide more frequently than slowly elongating cells. Importantly, the
physiologically distinct subpopulations of cells that arise through asymmetric growth and division
are differentially susceptible to clinically important classes of antibiotics.
Tuberculosis, caused by infection with Mycobacterium tuberculosis, remains a major global
health problem, killing more than 1.5 million people annually. While antibiotic therapy
rapidly reduces the bacterial burden, eliminating the infection requires long courses of
multiple antibiotics (1, 2). It has been suggested that this lengthy course of treatment is
required because the mycobacterial population is functionally heterogeneous and contains
cells that are differentially susceptible to antibiotics, non-replicating, or sequestered in the
body (3, 4). Because almost all antibiotics target bacterial processes involved in cell growth,
we hypothesized that there is heterogeneity in growth states of mycobacterial cells that
underlies differential antibiotic susceptibility.
To measure the growth and antibiotic susceptibility of mycobacteria at a single cell level, we
designed a microfluidic chamber to culture mycobacteria for live-cell imaging. This device
allows cell movement in two-dimensions but constrains bacteria to a single focal plane (Fig.
1A). Cells are grown in shallow channels that are connected to a perpendicular media
channel, which provides a homogeneous mixture of nutrients by diffusion. This device
enables us to image mycobacterial growth for up to five generations at which point images
become too crowded to score (Fig. 1B). In this device, we can expose cells to defined
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stressors such as antibiotics, and follow the responses of individual cells. As the growth and
division machinery is highly conserved between pathogenic and nonpathogenic
mycobacteria, we focused our live-cell imaging experiments on the experimentally tractable,
model mycobacterium, Mycobacterium smegmatis.
To assess population variation in growth states, we measured the elongation rates of
individual M. smegmatis cells grown in rich medium. As a point of comparison, we also
measured the growth parameters of individual Escherichia coli cells grown in rich medium
in our microfluidic device. We found significantly more variability in the elongation rates of
mycobacterial cells compared to E. coli cells (Fig. 1C; F<0.05 (5)). Mycobacteria lack the
molecular rulers that ensure symmetric cell division, which place the division septum in the
center of the cell in other rod shaped organisms such as E. coli and Bacillus subtilis (6).
Thus, we wondered whether the variability in mycobacterial elongation rates was related to
asymmetry in cell division (7, 8). We therefore assessed the symmetry of mycobacterial cell
division and found that cell division is significantly less symmetric in M. smegmatis than in
E. coli (Fig. 1D; F<.001 (5)). We observed similar asymmetry in cell division in M.
tuberculosis (fig. S1).
Asymmetry in cell elongation could cause apparent asymmetry in cell division and
subsequent variability in the elongation rates of daughter cells. To assess this possibility, we
took advantage of the fact that mycobacteria elongate at their poles rather than along the
lateral cell body as in E. coli (6, 9). This allowed us to quantify cell elongation by pulse
labeling the cell wall with a fluorescent amine reactive dye and measuring the extension of
the unlabeled poles (Fig. 2A; (10)). Strikingly, we found that mycobacterial cells elongate
preferentially at the old pole (Fig. 2B and C). In static images, unipolar growth produces a
“cigar-band” of cell wall labeling with the amine reactive dye where one pole has elongated
significantly more than the other, which we also observe in M. tuberculosis (Fig. 2D).
Unipolar growth per se does not explain cell-to-cell variability in elongation rates or cell
sizes but it does create different types of cells at division. One daughter cell inherits the
growing pole while the other daughter cell must create a new growth pole after every
division (schematic in Fig. 2E). The new growth pole is generated at the older pole (opposite
the division septum), and therefore the direction of growth changes with every cell cycle.
We have quantified this for a single, representative cell over four generations in Fig. 2E. By
contrast, in the daughter cell that inherits the growing pole (indicated by an arrow in Fig.
2E), elongation continues from the inherited growth pole (fig. S2).
We hypothesized that the daughter cell inheriting the growth pole would elongate at a
different rate than its sister cell, which must assemble a new growth pole. We tested this
hypothesis by computing the differences in elongation rate between pairs of sister cells. We
found that on average, the sister cell inheriting the growth pole elongates faster than the
sister cell that establishes a new growth pole (Fig. 3A; p<0.05). The cell inheriting the
growth pole is also longer at birth than its sister cell, consistent with a model in which
elongation remains asymmetric during septation (Fig. 3B; p<0.05). Thus, each division
results in two distinctive sister cells. We term these cells accelerators, which inherit the
mother’s growth pole and tend to elongate faster, and alternators, which must regenerate a
new growth pole and tend to elongate more slowly (Fig. 3C).
By definition, all alternator cells have new growth poles, while accelerator cells inherit
growth poles of varying ages. Some accelerator cells inherit growth poles created in the
previous generation while others inherit growth poles created several generations earlier. To
understand whether growth pole age impacts the elongation rate of accelerator cells, we
mapped the pedigrees of single cells. We assigned an “age” to a cell based on the number of
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generations its growth pole had experienced; alternator cells have an age of one and
accelerator cells have an age of two or greater (Fig. 3C). We then compared the elongation
rate of cells of different ages in populations arising from a single cell, which we term a
microcolony. Cells with older growth poles elongate faster than cells with younger growth
poles (Fig. 3D, p<0.05 for accelerator vs. alternator cells). In addition, the birth length of
cells increases as the growth pole matures (Fig. 3E, p<0.05 for accelerator vs. alternator
cells and age three vs. age two cells). Taken together, these data suggest that as the growth
pole matures, cells elongate faster and are larger. Of note, we occasionally observed cells
with older growth poles that elongated more slowly than cells with younger growth poles in
the same microcolony (e.g. Fig. 3D, colony G), suggesting there may be a mechanism to
“reset” the elongation rate.
These data show that the mycobacterial growth pattern generates a population of cells that is
heterogeneous in size and elongation rates. We assessed whether rapidly elongating cells
also divide more frequently than slowly elongating cells, as would be expected if
mycobacteria control cell cycle entry using sized based regulation like E. coli (11, 12).
Alternatively, mycobacteria might regulate entry into the cell cycle using a time-based
mechanism. In yeast, investigators have differentiated between size- and time-based cell
cycle regulation using the relationship between birth length and elongation length (13, 14).
In cells that employ size-based cell cycle regulation, small cells must grow more before
dividing causing the birth length to be negatively correlated with elongation length, while in
time-based regulation, these lengths are uncorrelated. We therefore measured the association
between the birth and elongation lengths of M. smegmatis cells. We found no correlation
between the two lengths in M. smegmatis (regression line slope of 0.00; Fig. 4A), while in
E. coli we found these lengths to be negatively correlated, as expected (regression line slope
of −0.75; fig. S3A). These data suggest that the mycobacterial division cycle, which we use
as a measure of the cell cycle more broadly, is regulated by time rather than size. Consistent
with time-based regulation of cell cycle progression, cell division is synchronized in a
microcolony, with closely related cells dividing at similar times (Fig. 4B and fig. S3B). We
calculated the microcolony division cycle length by characterizing the distribution of
division events in time and in the frequency domain using a Fourier transform (Fig. 4B and
fig. S3B). The major frequency corresponds to the division cycle length (and is unbiased by
the increasing number of cells as the colony grows) and the amplitude of the peak is a metric
for synchronization in the colony. The colony cycle times calculated from the mean and the
frequency domain are very similar (within 0.2 h for each microcolony). However, there were
significant differences in cycle times between some microcolonies (fig. S3C). These data
suggest that as yet unidentified factors may modulate the cell cycle timer, compounding the
diversity of elongation states within the population. It is also important to note that the cell
cycle length is much longer in slow-growing mycobacteria (~22 hours in M. tuberculosis as
compared to ~3 hours in M. smegmatis). It is also therefore possible that growth and
division cycle timing in M. tuberculosis is subject to additional layers of regulation that are
not reflected in these studies.
Thus, asymmetric elongation and cell division and a timed cell cycle quickly create a
population of mycobacterial cells that vary in their elongation rates, sizes and perhaps other
physiologic properties. Since antibiotics target processes essential for growth and division,
we hypothesized that these cells might be differentially sensitive to antibiotics. We therefore
sought to determine the susceptibility of alternator and accelerator cells to treatment with
different classes of antibiotics. To do this, we used live cell imaging to establish the
pedigrees of growing cells and challenged them with the indicated antibiotics at the
minimum inhibitory concentrations. We identified bacterial survival by scoring for post-
treatment regrowth in 25–66 independent microcolonies. Because we observed variability
between microcolonies in the efficacy of some antibiotics, especially isoniazid and
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rifampicin, we calculated the difference in bacterial survival between accelerator and
alternator cells for each microcolony and assessed the distribution of this differential across
all microcolonies.
Given their different rates of elongation and potential differences in cell wall composition,
we predicted that accelerator cells would be more susceptible to cell wall synthesis
inhibitors than alternator cells. Indeed, accelerator cells were significantly more sensitive
than alternator cells to the peptidoglycan synthesis inhibitors, cycloserine and meropenem
(Fig. 4C and fig. S4; p<0.05). Accelerator cells were also more sensitive than alternator cells
to isoniazid, which blocks synthesis of cell wall mycolic acids, although there was more
variability between microcolonies in the effectiveness of isoniazid (Fig. 4C and fig. S4;
p<0.05). However, accelerator cells are not universally more susceptible to antibiotic
treatment. Strikingly, when microcolonies are treated with rifampicin, which inhibits RNA
polymerase, alternator cells were more susceptible than accelerator cells (Fig. 4C and fig.
S4; p<0.05). As in the case of isoniazid, there was variability among microcolonies in
response to rifampicin, suggesting that other potentially heritable factors may also contribute
to a cell’s susceptibility to these drugs. Thus, we find that alternator and accelerator cells
vary in their susceptibility to different classes of antibiotics, consistent with the model that
asymmetric growth and division creates physiologically distinct subpopulations of cells.
In this study, we show that growth and division in mycobacteria is distinct from better
characterized model bacteria. Although unusual, the mycobacterial growth pattern contains
spatial and temporal elements that are similar to those used by other bacteria to achieve
rapid functional diversification of closely related cells (15–21). The most obvious example
of this is Caulobacter crescentis, which also exploits polar asymmetry, asymmetry at cell
division, and age-dependent changes in pole function to rapidly create a dimorphic
population (15, 22–25). In these organisms and in mycobacteria, variable growth and
division patterns create deterministic population diversity at a very high frequency.
Mycobacteria may also use other lower frequency mechanisms, both deterministic and
stochastic, to generate a tapestry of cell types (26–29). We anticipate that if these
mechanisms for bacterial diversification operate in M. tuberculosis as they do in M.
smegmatis, they may contribute to the highly variable outcomes of tuberculosis infection
and treatment.
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Figure 1. M. smegmatis exhibits heterogeneous growth characteristics
(A) Schematic diagram of the microfluidic device used for long-term imaging of
mycobacteria. Media flows through the main channel (large arrow) and provides nutrients
(cyan circles) by diffusion (small arrows) to the cells. (B) Bright-field, time-lapse imaging
of M. smegmatis in the microfluidic device.. (C) Distribution of average (mean centered)
elongation rates of 322 individual M. smegmatis (blue; left axis) and 102 E. coli (green;
right axis) cells averaged over the course of one cell cycle. The mean elongation rates were
1.15 μm/h for M. smegmatis and 3.72 μm/h for E. coli. (D) Distribution of division
symmetry for 166 M. smegmatis (blue; left axis) and 105 E. coli (green; right axis) pairs of
sister cells. Division symmetry is calculated as the ratio of the length of the smaller sister to
the sum of the lengths of both sisters at division.
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Figure 2. M. smegmatis growth is asymmetric and elongation occurs from the old pole
(A) Schematic diagram of the pulse-chase experiment used to measure polar growth. Cells
were labeled with amine reactive dye (green) and growth was assessed by measuring the
extension of the unlabeled region (red arrows). Cell wall-labeling did not alter cell
elongation rate (fig. S5A), other labeling chemistries such as hydroxylamine labeling via
periodate oxidation led to similar staining patterns (data not shown), and similar labeling
patterns were seen in cells grown in broth and in microfluidic channels (fig. S5B). (B) Time-
lapse imaging of two sister cells following the pulse-labeling (green) of the cell wall. The
bright field images were pseudo-colored red. New poles are annotated with asterisks and the
old poles with arrows. Each cell’s poles are annotated with the same color asterisk and
arrow. A schematic is drawn above each image, marking the new poles and growth poles
with an asterisk and red arrow, respectively. We also used a fluorescein-vancomycin
conjugate (Van-FL) to stain nascent peptidoglycan (30) and found preferential labeling of
the old pole over the new pole (fig. S5C). (C) Growth over one cell cycle at new versus old
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poles in 50 cells (*p<0.001 by a Mann-Whitney rank sum test). There was no cell in which
the new pole elongated more than the old pole. (D) Three representative images of M.
tuberculosis (left) and M. smegmatis (right) following the pulse-labeling (green) of the cell
wall (after 48 hours in broth culture for M. tuberculosis and six hours in the microfluidic
device for M. smegmatis). The bright field images are pseudo-colored red. Size bars
represent 1.3 μm. Comparison images of E. coli labeled under similar conditions may be
found in fig. S5D. (E) Cumulative polar growth for one labeled cell plotted for each pole
through four cell cycles. The cell inheriting the new pole alternates the direction of growth
after division events.
Aldridge et al. Page 9













Figure 3. Division creates sister cells with different growth properties
(A–B) Distribution of the differences in elongation rate (A) and birth length (B) between
sister cells inheriting the old pole and the new pole. The distributions are skewed (p<0.05;
red lines denote zero), indicating that the sister inheriting the older pole elongates faster (in
71% of the 161 sister pairs) and is larger at division (in 74% of the 161 sister pairs). In 7.5%
of the 161 sister pairs, the sister that inherited the new pole elongated faster and was longer
at birth than its sister. (C) Schematic model for mycobacterial growth. A labeled cell (green)
is shown to elongate from one pole (red arrow). Two sister cells are created at division: an
accelerator (Acc) cell inheriting the old (growing) pole and an alternator (Alt) cell inheriting
the new pole. Growth pole age (in generations) is labeled in purple. (D–E) Elongation rate
(D) and birth lengths (E) are plotted for ten microcolonies, with cell subpopulations grouped
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by growth pole age. Growth pole age was scored by mapping the pedigrees of unlabeled
cells through several generations via live cell imaging. Subpopulation means (large ovals)
are plotted along with data from individual cells (small circles). Elongation rate and birth
length increase within a colony as the growth poles age (p<0.05 for alternator vs. accelerator
elongation rates; and p<0.05 for alternator vs. accelerator and age two vs. age three birth
lengths).
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Figure 4. Population heterogeneity of growth characteristics is maintained by time-based cell
division cycle regulation and contributes to differential susceptibility to antibiotic stress
(A) Birth length and elongation length, which is defined as the length that the cell elongates
between birth and division, are uncorrelated for 322 M. smegmatis cells (regression slope of
0.00), suggesting that mycobacteria use time to regulate their cell cycle. (B) Cell cycle
timing is characterized for one microcolony (a second representative microcolony is shown
in fig. S3B). Division events are plotted in the time domain as discrete events (blue circles;
left axis) and as a histogram (red line; right axis). The histogram of birth events was used to
generate an amplitude spectrum with a Fourier transform, shown in the lower left plot. The
peak represents the cycle time of the microcolony (arrow). The spread of cycle times for
individual cells is shown here as histogram in the lower right. (C) Distributions of the
difference in bacterial survival between accelerator and alternator cells for each microcolony
following treatment with meropenem, cycloserine, isoniazid, and rifampicin at minimal
inhibitory concentrations (2.3 mM, 0.04 mg/ml, 25 μM, and 50 μM, respectively; p<0.05
for each distribution). Survival was scored by determining the percentage of cells that were
able to regrow after antibiotic was removed. The analysis includes 317 cells in 25
microcolonies for meropenem, 374 cells in 26 microcolonies for cycloserine, 334 cells in 25
microcolonies for isoniazid, and 453 cells in 66 microcolonies for rifampicin.
Aldridge et al. Page 12
Science. Author manuscript; available in PMC 2012 July 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
